MNTN heads into the week after its May 5 earnings with a sharp price recovery that has outrun the Street's revised expectations.
The stock rallied 7.4% on Tuesday and is up 13.6% over the past five sessions, taking the one-month gain to nearly 27%. That brings it to $11.36 — still well below the consensus price target of around $19.67, implying roughly 73% upside on the Street's numbers even after a wave of target cuts. The tension here is straightforward: investors are buying, analysts are trimming, and the gap between where the stock trades and where analysts think it belongs has widened rather than narrowed.
The Street's reaction to the Q1 print was uniformly cautious on targets, even where conviction held. Morgan Stanley's Matthew Cost lowered his price target from $20.50 to $18 as recently as today while keeping an Equal-Weight rating. Citizens trimmed to $19 from $23, also holding its Outperform call. Canaccord Genuity had already cut to $18 before the print in April. The pattern is consistent: every firm that has moved in the past three months has cut its number, yet none has downgraded. Five analysts cover the stock and all five rate it a buy or equivalent. Bulls point to 28–31% revenue growth rates and a path to roughly $610 million in revenue by FY30. Bears flag the stock's post-IPO volatility, the risk that advertising technology competition intensifies, and the gap between current trading levels and initial offering prices. With the EV/EBITDA multiple running near 5.8x and a P/E around 10.9x — both drifting higher over the past month as the price has recovered — valuation is getting less cheap, though the multiples still look undemanding relative to growth.
Positioning is decidedly loose, which makes the price move harder to attribute to short-covering pressure. Short interest is modest at just under 4% of the free float — not crowded by any measure. Borrow availability is exceptionally wide at around 3,400% of short interest, meaning the lending pool is nearly untouched relative to the volume of shares borrowed. The cost to borrow has eased about 25% over the week to 0.44%, down from levels around 0.82% in mid-April. Nothing in the borrow market explains the rally. Options are mildly bullish by recent standards: the put/call ratio is running at 0.71, roughly 1.3 standard deviations below its 20-day average of 0.77, suggesting options traders have grown incrementally more call-skewed. The ORTEX short score of 35 — near the middle of its recent range — reinforces the picture of a stock where short sellers are neither pressing nor retreating.
Wellington Management and BlackRock both added to their positions in recent filings, with Wellington adding around 385,000 shares and BlackRock around 680,000. Those moves look incremental rather than aggressive, but they represent two mainstream institutional names stepping in. The largest holders — Greycroft, Baroda Ventures, and Mercato Partners — each hold roughly 7–9% of shares and have reported no changes in their most recent filings, suggesting the pre-IPO investor base is sitting tight.
The next scheduled catalyst is a June 11 earnings event. Between now and then, the key question is whether the price gap to analyst targets draws in incremental institutional buyers, or whether the relentless pattern of target cuts — every firm that has moved since December has moved lower — begins to weigh on sentiment as the next print approaches.
See the live data behind this article on ORTEX.
Open MNTN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
